Published date: 19 December 2017

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 22 September 2017

Contract summary

Industry

  • Blood coagulants - 33141530

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£302,000,000

Procurement reference

tender_140982/639280

Published date

19 December 2017

Closing date

22 September 2017

Contract start date

1 February 2018

Contract end date

31 January 2019

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No


Description

NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.


Award information

Awarded date

24 November 2017

Contract start date

1 February 2018

Contract end date

31 January 2019

Total value of contract

£302,000,000

This contract was awarded to 5 suppliers.

Baxalta Limited

Address

1 Kingdom Street, London, W2 6BD

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Bayer Plc

Address

400 South Oak Way, Green Park, Reading, Berkshire, RG2 6AD

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Novo Nordisk Limited

Address

3 City Place, Beehive Ring Road, Gatwick, RH6 0PA

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Octapharma Limited

Address

The Zenith Building, 26 Spring Gardens, Manchester, M2 1AB

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Pfizer Limited

Address

Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No


About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

philip.grieve@nhs.net